VDB-32828 · CVE-2006-5374 · BID 20588

Oracle Pharmaceutical 4.5.1 MACE Remote Code Execution

CVSS Meta Temp Score
CVSS is a standardized scoring system to determine possibilities of attacks. The Temp Score considers temporal factors like disclosure, exploit and countermeasures. The unique Meta Score calculates the average score of different sources to provide a normalized scoring system.
Current Exploit Price (≈)
Our analysts are monitoring exploit markets and are in contact with vulnerability brokers. The range indicates the observed or calculated exploit price to be seen on exploit markets. A good indicator to understand the monetary effort required for and the popularity of an attack.
CTI Interest Score
Our Cyber Threat Intelligence team is monitoring different web sites, mailing lists, exploit markets and social media networks. The CTI Interest Score identifies the interest of attackers and the security community for this specific vulnerability in real-time. A high score indicates an elevated risk to be targeted for this vulnerability.
9.3$0-$5k0.00

Summaryinfo

A vulnerability described as very critical has been identified in Oracle Pharmaceutical 4.5.1. This issue affects some unknown processing of the component MACE. Such manipulation leads to Remote Code Execution. This vulnerability is listed as CVE-2006-5374. In addition, an exploit is available.

Detailsinfo

A vulnerability was found in Oracle Pharmaceutical 4.5.1 and classified as very critical. Affected by this issue is an unknown code block of the component MACE. The manipulation with an unknown input leads to a remote code execution vulnerability. Impacted is confidentiality, integrity, and availability. CVE summarizes:

Unspecified vulnerability in Oracle Pharmaceutical Applications 4.5.1 has unknown impact and remote authenticated attack vectors, aka Vuln# PHAR01.

The weakness was presented 10/17/2006 by Esteban Martinez Fayo (Alex) with Application Security, Inc. (Website). The advisory is shared for download at us-cert.gov. This vulnerability is handled as CVE-2006-5374 since 10/17/2006. The exploitation is known to be easy. The attack may be launched remotely. No form of authentication is required for exploitation. Technical details are unknown but a public exploit is available. The current price for an exploit might be approx. USD (estimation calculated on 04/24/2026).

The exploit is available at securityfocus.com. It is declared as proof-of-concept. As 0-day the estimated underground price was around $25k-$100k.

There is no information about possible countermeasures known. It may be suggested to replace the affected object with an alternative product. Furthermore it is possible to detect and prevent this kind of attack with TippingPoint and the filter 9066.

The vulnerability is also documented in the databases at SecurityFocus (BID 20588†), OSVDB (31383†), Secunia (SA22396†), SecurityTracker (ID 1017077†) and Vulnerability Center (SBV-12951†). See VDB-2615, VDB-2614, VDB-33021 and VDB-32832 for similar entries. Once again VulDB remains the best source for vulnerability data.

Productinfo

Vendor

Name

Version

License

Website

CPE 2.3info

CPE 2.2info

CVSSv4info

VulDB Vector: 🔍
VulDB Reliability: 🔍

CVSSv3info

VulDB Meta Base Score: 9.8
VulDB Meta Temp Score: 9.3

VulDB Base Score: 9.8
VulDB Temp Score: 9.3
VulDB Vector: 🔍
VulDB Reliability: 🔍

CVSSv2info

AVACAuCIA
💳💳💳💳💳💳
💳💳💳💳💳💳
💳💳💳💳💳💳
VectorComplexityAuthenticationConfidentialityIntegrityAvailability
UnlockUnlockUnlockUnlockUnlockUnlock
UnlockUnlockUnlockUnlockUnlockUnlock
UnlockUnlockUnlockUnlockUnlockUnlock

VulDB Base Score: 🔍
VulDB Temp Score: 🔍
VulDB Reliability: 🔍

NVD Base Score: 🔍

Exploitinginfo

Class: Remote Code Execution
CWE: Unknown
CAPEC: 🔍
ATT&CK: 🔍

Physical: No
Local: No
Remote: Yes

Availability: 🔍
Access: Public
Status: Proof-of-Concept
Download: 🔍

EPSS Score: 🔍
EPSS Percentile: 🔍

Price Prediction: 🔍
Current Price Estimation: 🔍

0-DayUnlockUnlockUnlockUnlock
TodayUnlockUnlockUnlockUnlock

Threat Intelligenceinfo

Interest: 🔍
Active Actors: 🔍
Active APT Groups: 🔍

Countermeasuresinfo

Recommended: no mitigation known
Status: 🔍

0-Day Time: 🔍
TippingPoint: 🔍
SourceFire IPS: 🔍

Timelineinfo

10/17/2006 🔍
10/17/2006 +0 days 🔍
10/17/2006 +0 days 🔍
10/17/2006 +0 days 🔍
10/17/2006 +0 days 🔍
10/17/2006 +0 days 🔍
10/18/2006 +1 days 🔍
10/19/2006 +1 days 🔍
03/12/2015 +3066 days 🔍
04/24/2026 +4061 days 🔍

Sourcesinfo

Vendor: oracle.com

Advisory: us-cert.gov
Researcher: Esteban Martinez Fayo (Alex)
Organization: Application Security, Inc.
Status: Confirmed
Confirmation: 🔍

CVE: CVE-2006-5374 (🔍)
GCVE (CVE): GCVE-0-2006-5374
GCVE (VulDB): GCVE-100-32828
SecurityFocus: 20588 - Oracle October 2006 Security Update Multiple Vulnerabilities
Secunia: 22396 - Oracle Products Multiple Vulnerabilities, Highly Critical
OSVDB: 31383 - Oracle Pharmaceutical Applications Clinical Remote Data Capture Option Unspecified HTTP Issue
SecurityTracker: 1017077
Vulnerability Center: 12951 - Oracle Critical Patch Update Oct2006- Unspecified Vulnerability in Pharmaceutical Applications 4.5.1, Low
Vupen: ADV-2006-4065

scip Labs: https://www.scip.ch/en/?labs.20161013
See also: 🔍

Entryinfo

Created: 03/12/2015 22:21
Updated: 04/24/2026 19:44
Changes: 03/12/2015 22:21 (72), 07/10/2019 07:13 (3), 04/24/2026 19:44 (17)
Complete: 🔍
Cache ID: 216::103

Once again VulDB remains the best source for vulnerability data.

Discussion

No comments yet. Languages: en.

Please log in to comment.

◂ PreviousOverviewNext ▸

Might our Artificial Intelligence support you?

Check our Alexa App!